These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 36560848)
21. Grade II/III Glioma Microenvironment Mining and Its Prognostic Merit. Chen J; Hou C; Wang P; Yang Y; Zhou D World Neurosurg; 2019 Dec; 132():e76-e88. PubMed ID: 31518750 [TBL] [Abstract][Full Text] [Related]
22. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype. Qi Y; Lv W; Liu X; Wang Q; Xing B; Jiang Q; Wang Z; Huang Y; Shu K; Lei T Biomed Res Int; 2023; 2023():6082635. PubMed ID: 36685667 [TBL] [Abstract][Full Text] [Related]
24. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas. Wu Y; Peng Z; Gu S; Wang H; Xiang W Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111 [TBL] [Abstract][Full Text] [Related]
25. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q Front Genet; 2022; 13():1053263. PubMed ID: 36712869 [No Abstract] [Full Text] [Related]
26. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas. Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L Front Immunol; 2020; 11():603341. PubMed ID: 33363544 [TBL] [Abstract][Full Text] [Related]
27. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis. Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197 [TBL] [Abstract][Full Text] [Related]
29. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma. Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124 [TBL] [Abstract][Full Text] [Related]
30. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers]. Liu J; Xu K; Ma L; Wang Y Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410 [TBL] [Abstract][Full Text] [Related]
31. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma. Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X Front Oncol; 2021; 11():682932. PubMed ID: 34123852 [TBL] [Abstract][Full Text] [Related]
32. B2M overexpression correlates with malignancy and immune signatures in human gliomas. Zhang H; Cui B; Zhou Y; Wang X; Wu W; Wang Z; Dai Z; Cheng Q; Yang K Sci Rep; 2021 Mar; 11(1):5045. PubMed ID: 33658560 [TBL] [Abstract][Full Text] [Related]
33. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q Front Immunol; 2022; 13():1011757. PubMed ID: 36325335 [TBL] [Abstract][Full Text] [Related]
34. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma. Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R Front Immunol; 2022; 13():990790. PubMed ID: 36248822 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas. Tan S; Spear R; Zhao J; Sun X; Wang P Front Genet; 2022; 13():905047. PubMed ID: 35832194 [TBL] [Abstract][Full Text] [Related]
36. A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma. Luo X; Wang Q; Tang H; Chen Y; Li X; Chen J; Zhang X; Li Y; Sun J; Han S Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676646 [No Abstract] [Full Text] [Related]
37. Identification and validation of an ECM organization-related gene signature as a prognostic biomarker and therapeutic target for glioma patients. Zhong Q; Zhong Q; Cai X; Wu R Genes Genomics; 2023 Sep; 45(9):1211-1226. PubMed ID: 37301776 [TBL] [Abstract][Full Text] [Related]
38. Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics. Lin WW; Ou GY; Zhao WJ J Cell Mol Med; 2021 Nov; 25(21):10111-10125. PubMed ID: 34597473 [TBL] [Abstract][Full Text] [Related]
39. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response. Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909 [TBL] [Abstract][Full Text] [Related]
40. Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma. Zhang S; Xiao X; Wang Y; Song T; Li C; Bao H; Liu Q; Sun G; Sun X; Su T; Fu T; Wang Y; Liang P Front Genet; 2022; 13():899125. PubMed ID: 35719378 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]